Floatz logo

D-thioctic acid

Ototoxicity

US Department of Veterans AffairsSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Ototoxicity cohort.

Asset / SponsorPhaseRating
Sodium Thiosulfate
Children's Oncology Group
Phase 3B
Spi-1005 Ebselen
Sound Pharmaceuticals, Incorporated
Phase 2B
Cholesterol Suspension
University of Colorado, Denver
Phase 2NR

Same molecule, other indications

D-thioctic acid is also rated in:

migraine disorderDormant
BB
Indicative ·
69 / 100
View asset →
Herpetic NeuralgiaDormant
BB
Indicative ·
69 / 100
View asset →
chronic progressive multiple sclerosisDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →